Content area

|
|

Screening for intrakranielle aneurismer

Forfatter(e)
Ronni Mikkelsen1, 2, John Hauerberg1, 3, Sune Munthe1, 4, Troels Halfeld Nielsen1, 4, Per Rochat1, 3, Peter Birkeland1, 5, Svetlana Rudnicka1, 6, Helga Angela Gulisano1, 5, Tom Sehested1, 7, Anabel Diaz1, 8, Sanja Karabegovic1, 2 & Niels Sunde1, 7
1) Neurovaskulært udvalg, Dansk Neurokirurgisk Selskab 2) Neuroradiologisk Afdeling, Aarhus Universitetshospital3) Neurokirurgisk Klinik, Rigshospitalet 4) Neurokirurgisk Afdeling, Odense Universitetshospital 5) Neurokirurgisk Afdeling, Aalborg Universitetshospital 6) Radiologisk Afdeling, Aalborg Universitetshospital 7) Neurokirurgisk Afdeling, Aarhus Universitetshospital 8) Radiologisk Afdeling, Odense Universitetshospital

Ugeskr Læger 2019;181:V05180375
Reference: 
Ugeskr Læger 2019;181:V05180375
Blad nummer: 

Ronni Mikkelsen, John Hauerberg, Sune Munthe, Troels Halfeld Nielsen, Per Rochat, Peter Birkeland, Svetlana Rudnicka, Helga Angela Gulisano, Tom Sehested, Anabel Diaz, Sanja Karabegovic & Niels Sunde:

Screening for intracranial aneurysms

Ugeskr Læger 2019;181:V05180375

This review states the reasons for considering screening for intracranial aneurysms in Denmark: if patients have two first-degree relatives with intracranial aneurysms, are 30-70 years old, do not have competing disorders, which could significantly shorten life expectancy, and subsequently in patients with autosomal dominant kidney disease and a family history of subarachnoid haemorrhage. MR angiography should be the imaging study of choice, unless contraindicated. Generally, the ethical consequences ought to be considered before carrying out screening.

Du skal være logget ind for at læse denne artikel
Log ind

Right side